Onychomycosis Treatment Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

How Will the Onychomycosis Treatment Market Grow, and What Is the Projected Market Size?
The onychomycosis treatment market has expanded significantly in recent years. It will grow from $3.65 billion in 2024 to $3.92 billion in 2025, at a CAGR of 7.4%. This growth can be attributed to a rising number of fungal infections, an aging population, greater public awareness, an increase in onychomycosis prevalence, and higher disposable incomes.

The onychomycosis treatment market is expected to see steady growth, reaching $5.09 billion by 2029 at a CAGR of 6.7%. The growth is attributed to the aging population, expansion of telemedicine, combination therapies, increasing healthcare access, and rising diabetes prevalence. Key trends include dermatological advancements, drug delivery innovations, personalized treatment plans, topical treatment advances, digital health solutions, and laser therapy.

What Key Elements Are Boosting Growth in the Onychomycosis Treatment Market?
The increasing incidence of fungal infections is anticipated to drive the growth of the onychomycosis treatment market. Fungal infections are microbial diseases caused by fungi, affecting different body parts and leading to various conditions. Onychomycosis, a fungal infection of the nails, is commonly treated with oral antifungal drugs or topical solutions to eliminate the infection and promote healthy nail regrowth. For instance, in September 2023, the UK Health Security Agency, a UK-based government body, recorded 2,265 cases of bloodstream infections (BSI) caused by yeast in England in 2022, as per SGSS data. The incidence rate of BSI due to yeast increased slightly to 4.0 per 100,000 population, up from 3.8 per 100,000 in 2021. The most frequently identified yeast species were Candida albicans (40%), Nakaseomyces glabratus (29%), and Candida parapsilosis (13%). Therefore, the increasing prevalence of fungal infections is fueling the expansion of the onychomycosis treatment market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12941&type=smp

Who Are the Major Industry Players Fueling Onychomycosis Treatment Market Expansion?
Major companies operating in the onychomycosis treatment market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Ltd., Sun Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., Intas Pharmaceuticals Limited, Cipla Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Aurobindo Pharma Limited, Alkem Laboratories Limited, Jubilant Life Sciences Ltd., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Biocon Limited, Emcure Pharmaceuticals Limited, Alembic Pharmaceuticals Ltd., Laurus Labs Limited, Strides Pharma Science Limited, Aarti Drugs Ltd., NATCO Pharma Ltd., Unichem Laboratories Ltd., Indoco Remedies Ltd., Apex Laboratories Pvt. Ltd., Wockhardt Ltd., Nuray Chemicals Private Limited.

Which Key Developments Are Influencing the Onychomycosis Treatment Market?
Major companies in the onychomycosis treatment market are concentrating on developing new treatment products, such as MOB-015, and securing regulatory approvals to strengthen their competitive standing. For instance, in June 2023, Moberg Pharma AB, a Sweden-based pharmaceutical company, gained approval for MOB-015 in the European Union for treating mild to moderate fungal nail infections in adults. This authorization marks the first global marketing approval for MOB-015. Supported by two Phase 3 trials, the product demonstrated a mycological cure rate of 76%, compared to a maximum of 42% for alternatives, along with a significantly higher total cure rate-all without severe adverse effects. MOB-015, a topical terbinafine formulation, allows effective concentrations to penetrate the nail and nail bed without the systemic risks associated with oral terbinafine treatments.

How Is the Segmentation of the Onychomycosis Treatment Market Defined?
The onychomycosis treatment market covered in this report is segmented -

1) By Type: Distal Sublingual Onychomycosis, White Superficial Onychomycosis, Proximal Sublingual Onychomycosis, Candida Onychomycosis, Other Types
2) By Treatment Type: Drugs, Laser Therapy, Photodynamic Therapy
3) By Age Group: 0 To 18 Years, 18 To 39 Years, 40 To 64 Years, 65 Years And Above
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report

What Is the Leading Region in the Onychomycosis Treatment Market?
North America was the largest region in the onychomycosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in onychomycosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Onychomycosis Treatment Global Market Report?

- Market Size Analysis: Analyze the Onychomycosis Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Onychomycosis Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Onychomycosis Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Onychomycosis Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12941

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.